K Number
K040893
Device Name
EASY CORE BIOPSY SYSTEM
Date Cleared
2004-05-06

(30 days)

Product Code
Regulation Number
876.1075
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The Easy Core Biopsy System is indicated for use endoscopically or percutaneously to retrieve tissue sampling of soft organs/tumors or masses for histological analysis. Soft tissue sampling includes but not limited to organs such as breast, liver, kidney and prostate.
Device Description
The Easy Core Biopsy System is a sterile, single-use biopsy needle.
More Information

Not Found

Not Found

No
The summary describes a mechanical biopsy needle and does not mention any software, algorithms, or data processing that would indicate the use of AI/ML.

No.
The device is used to retrieve tissue samples for analysis, which is a diagnostic procedure, not a therapeutic one.

Yes

Explanation: The device is used to retrieve tissue samples for histological analysis, which is a diagnostic process to determine the nature of diseases (e.g., distinguishing between benign and malignant tumors).

No

The device description explicitly states it is a "sterile, single-use biopsy needle," which is a physical hardware component.

Based on the provided information, the Easy Core Biopsy System is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVDs are used to examine specimens outside the body. They analyze samples like blood, urine, tissue, etc., to provide information about a person's health status.
  • The Easy Core Biopsy System is a device used to retrieve the tissue sample from the body. Its function is the collection of the specimen, not the analysis of it.
  • The intended use clearly states it's for "retrieving tissue sampling... for histological analysis." Histological analysis is the examination of tissue under a microscope, which is a separate process performed after the sample is collected.

Therefore, the Easy Core Biopsy System is a medical device used for tissue collection, which is a step that precedes the in vitro diagnostic process (histological analysis).

N/A

Intended Use / Indications for Use

The Easy Core Biopsy System is indicated for use endoscopically or percutaneously to retrieve tissue sampling of soft organs/tumors or masses for histological analysis. Soft tissue sampling includes but not limited to organs such as breast, liver, kidney and prostate.

Product codes (comma separated list FDA assigned to the subject device)

78 FCG

Device Description

The Easy Core Biopsy System is a sterile, single-use biopsy needle.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Soft organs/tumors or masses including breast, liver, kidney and prostate.

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

The Easy Core Biopsy System has been tested and compared to the predicate device. All data gathered demonstrate this device as substantially equivalent. No new issues of safety or efficacy have been raised.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

ASAP Biopsy System (Formally referred to as Stamey Sampler Spring Loaded Needle), ASAP 14g Biopsy System.

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 876.1075 Gastroenterology-urology biopsy instrument.

(a)
Identification. A gastroenterology-urology biopsy instrument is a device used to remove, by cutting or aspiration, a specimen of tissue for microscopic examination. This generic type of device includes the biopsy punch, gastrointestinal mechanical biopsy instrument, suction biopsy instrument, gastro-urology biopsy needle and needle set, and nonelectric biopsy forceps. This section does not apply to biopsy instruments that have specialized uses in other medical specialty areas and that are covered by classification regulations in other parts of the device classification regulations.(b)
Classification. (1) Class II (performance standards).(2) Class I for the biopsy forceps cover and the non-electric biopsy forceps. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.

0

MAY - 6 2004

Image /page/0/Picture/2 description: The image contains handwritten text. The first line reads 'K040893'. The second line reads 'Prze i vf i'.

Summary of Safety and Effectiveness

| General

ProvisionsTrade Name: Easy Core™
Classification Name: Biopsy System, Gastroenterology-urology
Name of
Predicate
DevicesASAP Biopsy System (Formally referred to as Stamey Sampler Spring
Loaded Needle), ASAP 14g Biopsy System.
ClassificationClass II
Performance
StandardsPerformance Standards have not been established by FDA under Section 514
of the Food, Drug and Cosmetic Act
Intended Use
and Device
DescriptionThe Easy Core Biopsy System is indicated for use endoscopically or
percutaneously to retrieve tissue sampling of soft organs/tumors or masses for
histological analysis. Soft tissue sampling includes but not limited to organs
such as breast, liver, kidney and prostate. The Easy Core Biopsy System is a
sterile, single-use biopsy needle.
BiocompatibilityThe Easy Core Biopsy System has been tested for biocompatibility per ISO
  1. All data demonstrate this device is biocompatable for its intended use. |
    | Summary of
    Substantial
    Equivalence | The Easy Core Biopsy System has been tested and compared to the predicate
    device. All data gathered demonstrate this device as substantially equivalent.
    No new issues of safety or efficacy have been raised. |

1

Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized caduceus symbol, which is a staff with two snakes entwined around it. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES-USA" are arranged in a circular pattern around the caduceus symbol.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

MAY - 6 2004

RE: K040893

Ms. Christine Cameron Regulatory Specialist II Boston Scientific Corporation One Boston Scientific Place NATICK MA 01760

Trade/Device Name: Easy Core Biopsy System Regulation Number: 21 CFR§ 876.1075 Regulation Name: Gastroenterology-Urology Biopsy Instruments

Regulatory Class: II Product Code: 78 FCG Dated: April 5, 2004 Received: April 6, 2004

Dear Ms. Cameron:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA). it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050.

2

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter:

8xx.1xxx(301) 594-4591
876.2xxx, 3xxx, 4xxx, 5xxx(301) 594-4616
884.2xxx, 3xxx, 4xxx, 5xxx, 6xxx(301) 594-4616
892.2xxx, 3xxx, 4xxx, 5xxx(301) 594-4654
Other(301) 594-4692

Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html.

Sincerely yours,

Nancy C. Brogdon

Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

3

K040893
Page 1 of 1

Indications For Use

510(k) Number (if known)Unknown K040893
Device Name:Easy Core™ Biopsy System
Indications for UseThe Easy Core Biopsy System is indicated for use endoscopically or percutaneously to retrieve tissue sampling of soft organs/tumors or masses for histological analysis. Soft tissue sampling includes but not limited to organs such as breast, liver, kidney and prostate.

Prescription Use × (Part 21 CFR 801 Subpart D) AND/OR

Over-The-Counter Use (21 CFR 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

(Division Sign-Off) Division of Reproductive, Abdominal, and Radiological Devices 040843 510(k) Number.